/
Arvinas, Inc.
Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
Mentions
2 mentions · latest on 9 Jul 2026
See which tracked investors hold Arvinas, Inc. →Ownership and position changes on OwnershipTrace